Clinical Trials Browser

Phase 1 × capmatinib × Tumor-Agnostic × Clear all

NCT01072266 2017-11-22

A Dose-escalation Study in Subjects With Advanced Malignancies

Phase 1 Completed

Neoplasm Metastasis